FLYSYN in MRD Positive AML

Clinical trial NCT02789254 · COMPLETED

Trial details

NCT number: NCT02789254
Sponsor: Synimmune GmbH
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2017-02-07
Primary completion: 2021-09-27
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.